Hossain Md Jubayer, Das Manisha, Shahjahan Muhibullah, Islam Md Wahidul, Towhid Syeda Tasneem
Population Health Studies Division Center for Health Innovation, Research, Action, and Learning-Bangladesh (CHIRAL Bangladesh) Dhaka Bangladesh.
Dhaka Medical College and Hospital Dhaka Bangladesh.
Health Sci Rep. 2025 Jan 17;8(1):e70356. doi: 10.1002/hsr2.70356. eCollection 2025 Jan.
Dengue is a mosquito-borne viral disease that frequently causes seasonal outbreaks in Bangladesh, particularly during the monsoon months from June to September. Recent outbreaks have shown significant shifts in clinical manifestations, including changes in the timeframe and serotype mixing. This study focused on the clinical and hematological profiles of patients during the 2022 outbreak, which was notably severe.
This quantitative cross-sectional study at Dhaka Medical College and Hospital classified 67 dengue-positive patients as having dengue fever (DF), dengue fever with warning signs (DFWS), and severe dengue (SD). Fisher's exact test, Pearson's chi-squared test, and Wilcoxon rank-sum test were conducted for statistical analysis using the R software (version 4.2), with significance established at < 0.05.
Predominantly male patients (76%) aged 21-40 (63%) and middle-class patients from Dhaka (57%) formed the majority. Most patients (45%) lacked a regular drainage system. Laboratory tests showed 63% NS1 antigen (nonspecific antigen 1) positivity, and 16% tested positive for both NS1 and IgM (Immunoglobulin M). Symptoms included headache (84%), retroorbital pain (51%), joint pain (75%), myalgia (72%), vomiting (75%), abdominal pain (69%), diarrhea (39%), and shock (48%). Thrombocytopenia was present in 61% of patients, with 79% showing elevated hematocrit (HCT) levels. Pedal edema, pleural effusion, and ascites were observed in DF and DFWS cases, while SD cases exhibited distinct HCT level variations.
Accurate clinical and laboratory assessments are vital for the treatment and prediction of dengue outcomes in Bangladesh, given the severe manifestations of dengue shock syndrome (DSS). It is characterized by headache, muscle pain, thrombocytopenia, anemia, leukopenia, and potential neurological complications or mortality. Severe cases involve critical plasma leakage, leading to DSS with fluid accumulation, respiratory distress, and potential multiorgan involvement. Enhancing physician awareness regarding dengue case detection and management, along with routine dengue testing, are recommended for early diagnosis and improved patient outcomes.
登革热是一种由蚊子传播的病毒性疾病,在孟加拉国经常引发季节性疫情,尤其是在6月至9月的季风月份。近期的疫情显示出临床表现有显著变化,包括发病时间框架的改变和血清型混合。本研究聚焦于2022年那次尤为严重的疫情期间患者的临床和血液学特征。
在达卡医学院和医院进行的这项定量横断面研究,将67名登革热阳性患者分为登革热(DF)、有警示体征的登革热(DFWS)和重症登革热(SD)。使用R软件(版本4.2)进行Fisher精确检验、Pearson卡方检验和Wilcoxon秩和检验以进行统计分析,显著性设定为<0.05。
主要是年龄在21 - 40岁的男性患者(76%)以及来自达卡的中产阶级患者(57%)占大多数。大多数患者(45%)没有正规的排水系统。实验室检测显示63%的患者NS1抗原(非特异性抗原1)呈阳性,16%的患者NS1和IgM(免疫球蛋白M)均呈阳性。症状包括头痛(84%)、眶后疼痛(51%)、关节疼痛(75%)、肌痛(72%)、呕吐(75%)、腹痛(69%)、腹泻(39%)和休克(48%)。61%的患者出现血小板减少,79%的患者血细胞比容(HCT)水平升高。在DF和DFWS病例中观察到足部水肿、胸腔积液和腹水,而SD病例表现出明显的HCT水平变化。
鉴于登革热休克综合征(DSS)的严重表现,准确的临床和实验室评估对于孟加拉国登革热治疗和预后预测至关重要。其特征为头痛、肌肉疼痛、血小板减少、贫血、白细胞减少以及潜在的神经并发症或死亡。重症病例涉及严重的血浆渗漏,导致伴有液体潴留、呼吸窘迫和潜在多器官受累的DSS。建议提高医生对登革热病例检测和管理的认识,并进行常规登革热检测,以实现早期诊断并改善患者预后。